NFKB1 and viral infectious disease: Our biochemical assays showed that human N4BP1 is targeted by 3Cpro for cleavage at glutamine 816 (Q816), which impairs its regulatory function in tumor necrosis factor alpha (TNFα)-triggered NF-κB-related inflammatory signaling but does not affect viral infection in tissue culture.